1. Pharmacokinetic assessment of rifampicin and des-acetyl rifampicin in carbon tetrachloride induced liver injury model in Wistar rats.
- Author
-
Sharma, Swati, Anand, Aishwarya, Taneja, Sunil, Sharma, Vishal, Bhatia, Alka, Patil, Amol N., and Banerjee, Dibyajyoti
- Subjects
PYRAZINAMIDE ,ISONIAZID ,LIQUID chromatography-mass spectrometry ,HYDROCARBONS ,TREATMENT effectiveness ,BILIRUBIN ,DESCRIPTIVE statistics ,OXIDATIVE stress ,LIVER diseases ,ANTITUBERCULAR agents ,RATS ,EXPERIMENTAL design ,ANIMAL experimentation ,COMPARATIVE studies ,DATA analysis software ,RIFAMPIN - Abstract
Preclinical evidence is needed to assess drug-metabolite behaviour in compromised liver function for developing the best antitubercular treatment (ATT) re-introduction regimen in drug-induced liver injury (DILI). The pharmacokinetic behavior of rifampicin (RMP) and its active metabolite des-acetyl-rifampicin (DARP) in DILI's presence is unknown. To study the pharmacokinetic behavior of RMP and DARP in the presence of carbon tetrachloride (CCl
4 ) plus ATT-DILI in rats. Thirty rats used in the experiment were divided equally into six groups. We administered a single 0.5 mL/kg CCl4 intraperitoneal injection in all rats. Groups II, III, IV, and V were started on daily oral RMP alone, RMP plus isoniazid (INH), RMP plus pyrazinamide (PZA), and the three drugs INH, RMP, and PZA together, respectively, for 21-days subsequently. Pharmacokinetic (PK) sampling was performed at 0, 0.5, 1, 3, 6, 12, and 24 h post-dosing on day 20. We monitored LFT at baseline on days-1, 7, and 21 and sacrificed the rats on the last day of the experiment. ATT treatment sustained the CCl4 -induced liver injury changes. A significant rise in mean total bilirubin levels was observed in groups administered rifampicin. The triple drug combination group demonstrated 1.43- and 1.84-times higher area-under-the-curve values of RMP (234.56±30.66 vs. 163.55±36.14 µg h/mL) and DARP (16.15±4.50 vs. 8.75±2.79 µg h/mL) compared to RMP alone group. Histological and oxidative stress changes supported underlying liver injury and PK alterations. RMP metabolism inhibition by PZA, more than isoniazid, was well preserved in the presence of underlying liver injury. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF